Effects of dietary fat on pancreatitis recurrence
Official title: The Effect of Dietary Fat Content on the Recurrence of Pancreatitis (EFFORT): Protocol of a Multicentre Randomized Controlled Trial
Run by University of Pecs · NCT04761523 · Data updated 2026-11-12
This study is testing if a low-fat diet can help people who have had multiple episodes of acute pancreatitis avoid getting it again.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 14 Years and up |
| Sex | All |
| Enrollment | 384 (estimated) |
| Sponsor | University of Pecs Academic / other |
| Locations | 1 site (Budapest) |
| Status | Recruiting |
| Started | May 1, 2022 |
| Main results expected | December 31, 2024 |
| Study ends | December 31, 2026 |
| Registry record updated | November 15, 2022 |
| Trial ID | NCT04761523 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals over 14 years old who have experienced at least two episodes of acute pancreatitis in the past two years, with the last episode being idiopathic.
✕Probably not a fit
Patients with critical conditions, active malignancies, or those receiving regular nutritional guidance may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial investigates how different dietary fat contents affect the recurrence of acute pancreatitis and associated mortality. Participants with a history of at least two episodes of acute pancreatitis will be randomized into two groups: one following a reduced fat diet and the other adhering to a standard healthy diet. Over a two-year period, participants will receive dietary interventions and complete food frequency questionnaires, while their health data, including mortality, BMI, and serum lipid levels, will be monitored. The goal is to determine if a low-fat diet can effectively reduce the recurrence of acute pancreatitis in idiopathic cases.
Why it matters
Potential benefit: If successful, this study could provide a dietary intervention to significantly reduce the recurrence of acute pancreatitis in patients.
How similar studies have gone: While dietary interventions have been suggested, this specific approach to reducing dietary fat in pancreatitis patients is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals with at least two episodes of acute pancreatitis in the 2 years preceding the inclusion with * The last episode being idiopathic, who are * Older than 14 years. Exclusion Criteria: * Individuals already receiving regular nutritional guidance (with medical indication), * Individuals in critical condition or in terminal stage of cancer (with an expected survival \<2 years) , * Individuals undergoing treatment for active malignancy, * Individuals with uncontrolled diabetes mellitus (admitted lack of compliance with antidiabetic therapy / HbA1c \>6.5% / indication of uncontrolled diabetes mellitus in last 24 months' anamnesis / newly discovered diabetes mellitus) * Individuals with known cholecystolithiasis * Individuals who are pregnant or nursing * Individuals with a BMI \< 18.5 * Individuals who are regularly receiving systemic corticosteroids * Individuals consuming more alcohol than: 5 units per day or 15 units per week for men; 4 units per day or 8 units per week for women.
Where it's running
-
Division of Pancreatic Diseases, Heart and Vascular Center, Semmelweis University
Budapest, Hungary Recruiting
Study contacts
- Study coordinator: Péter Hegyi, MD, PhD, DSc
- Email: hegyi2009@gmail.com
- Phone: +36703751031
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Local complications of acute pancreatitis and postoperative pancreatic fistula: what happens in real life
This multicenter registry tests how local pancreatic complications are managed in routine care and what outcomes look like over 180 days for adults.
-
SGC001 is being tested to help predicted severe acute pancreatitis
Researchers are testing SGC001 vs placebo in adults with predicted severe acute pancreatitis to see if it is safe and tolerable and to get a sense of any early effects.
-
Fecal microbiota transplant to prevent infections after late-phase severe acute pancreatitis
This trial will test whether giving healthy donor gut bacteria (fecal microbiota transplantation) through a feeding tube in the late phase of moderately severe or severe acute pancreatitis can prevent infectious complications.
-
How often splanchnic vein clots occur in acute pancreatitis and whether they relate to disease severity
This project will see if people with acute pancreatitis develop blood clots in the splenic, portal, or superior mesenteric veins and whether those clots are linked to more severe illness.
-
Fecal microbiota transplant for people with moderate to severe acute pancreatitis
This trial will test whether a fecal microbiota transplant (FMT) can reduce late complications in adults with moderate to severe acute pancreatitis.
-
Blood markers to detect infected pancreatic necrosis
We will test whether specific blood markers can help predict or diagnose infected pancreatic necrosis in adults with necrotizing pancreatitis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.